A.A. Valiev1, L.L. Galimova2, A.R. Zubkova1
1Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic named after prof. M.Z. Sigal, Kazan
2Kazan State Medical University, Kazan
Valiev Amir A. — Cand. of Sci. (Med.), oncologist, head of department №9 of the Republican Clinical Oncology Dispensary of Ministry of Healthcare of Tatarstan Republic named after prof. M.Z. Sigal
31 Sibirskiy trakt, Kazan, 420029, Russian Federation, tel.: (843) 202-24-16, +7-903-343-71-89, e-mail: firstname.lastname@example.org, ORCID ID: 0000-0002-7499-500X
Abstract. In 2020, more than 18 million cases of cancer were recorded worldwide, amongst which hepatic cancer ranked sixth. Colorectal cancer, which ranks third, gives rise to secondary liver tumors. Several options are available to treat this disease. Currently, one of the leading strategies is liver resection, which can be done either standalone or in combination with radiotherapy and chemotherapy. The history of laparoscopic liver resection (LLR) dates back to 1991, and has been evolving continuously. However, there are certain challenges preventing this: the lack of equipments in hospitals and their cost, and as a result, the lack of skilled surgeons. This review will cover LLR in various malignancies, as well as its comparison with the open resection method (efficacy, safety, results, costs).
Key words: liver cancer, laparoscopic liver resection, colorectal cancer.